Medtronic’s (MDT) Prestige LP cervical disc received FDA Premarket Approval for 2-level cervical disc replacement.
Seven-year follow-up data, announced in 2Q16, demonstrated favorable clinical outcomes and patient satisfaction for Prestige LP vs. 2-level anterior cervical discectomy and fusion (ACDF).
The device, which received approval for 1-level cervical disc replacement in 2014, is the third cervical disc in MDT’s portfolio, alongside BRYAN and Prestige ST.
Prestige LP and LDR’s Mobi-C are the only two cervical discs approved for 2-level cervical disc replacement in the U.S. In late 2Q16, Zimmer Biomet announced its intent to acquire LDR.
Sources: FDA.gov, ORTHOWORLD Inc.
Medtronic's (MDT) Prestige LP cervical disc received FDA Premarket Approval for 2-level cervical disc replacement.
Seven-year follow-up data, announced in 2Q16, demonstrated favorable clinical outcomes and patient satisfaction for Prestige LP vs. 2-level anterior cervical discectomy and fusion (ACDF).
The device, which received approval for...
Medtronic’s (MDT) Prestige LP cervical disc received FDA Premarket Approval for 2-level cervical disc replacement.
Seven-year follow-up data, announced in 2Q16, demonstrated favorable clinical outcomes and patient satisfaction for Prestige LP vs. 2-level anterior cervical discectomy and fusion (ACDF).
The device, which received approval for 1-level cervical disc replacement in 2014, is the third cervical disc in MDT’s portfolio, alongside BRYAN and Prestige ST.
Prestige LP and LDR’s Mobi-C are the only two cervical discs approved for 2-level cervical disc replacement in the U.S. In late 2Q16, Zimmer Biomet announced its intent to acquire LDR.
Sources: FDA.gov, ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





